Epstein-Barr virus-associated lymphoproliferative disorders

被引：199
|
作者：
Rezk, Sherif A. [1 ]
Weiss, Lawrence M. [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA 91010 USA
来源：
HUMAN PATHOLOGY | 2007年 / 38卷 / 09期
关键词：
epstein-Barr virus; B-cell lymphoproliferative; disorders; T-cell lymphoproliferative; HIV-associated lymphoproliferative disorders;
D O I：
10.1016/j.humpath.2007.05.020
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Epstein-Barr virus (EBV) is a member of the human herpesvirus family that was initially isolated from a cultured Burkitt lymphoma cell line by Epstein et al in 1964. Subsequent studies have proven that it is the causative agent in most cases of infectious mononucleosis. Primary infection is usually asymptomatic in childhood; but in adulthood, it is associated with a self-limiting infectious mononucleosis syndrome in approximately one third of the cases. EBV has been linked to many human neoplasms including hematopoietic, epithelial, and mesenchymal tumors. In this review, we will only discuss the EBV-associated lymphoproliferative disorders, dividing them into B-cell, T/NK-cell, and HIV-related lymphoproliferative disorders. (c) 2007 Published by Elsevier Inc.
引用
收藏
页码：1293 / 1304
页数：12
相关论文
共 50 条
  • [31] THE EPSTEIN-BARR VIRUS AND HUMAN LYMPHOPROLIFERATIVE DISORDERS
    SCHNIPPER, LE
    [J]. PROGRESS IN HEMATOLOGY, 1981, 12 : 275 - 297
  • [32] Epstein-Barr Virus-Associated Lymphomas
    Grywalska, Ewelina
    Rolinski, Jacek
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (02) : 291 - 303
  • [33] Epstein-Barr virus-associated cholecystitis
    Koch, Arjun D.
    van den Bosch, Harry C. M.
    Bravenboer, Bert
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (11) : 826 - 827
  • [34] EPSTEIN-BARR VIRUS-ASSOCIATED MALIGNANCIES
    RICHTSMEIER, WJ
    WITTELS, EG
    MAZUR, EM
    [J]. CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1987, 25 (02): : 105 - 136
  • [35] Epstein-Barr virus-associated lymphomas
    Rickinson, AB
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 29 - 29
  • [36] An Epstein-Barr virus-associated superantigen
    Sutkowski, N
    Palkama, T
    Ciurli, C
    Sekaly, RP
    ThorleyLawson, DA
    Huber, BT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03): : 971 - 980
  • [37] Epstein-Barr virus-associated lymphomas
    Shannon-Lowe, Claire
    Rickinson, Alan B.
    Bell, Andrew I.
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2017, 372 (1732)
  • [38] Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas
    Kingma, DW
    Weiss, WB
    Jaffe, ES
    Kumar, S
    Frekko, K
    Raffeld, M
    [J]. BLOOD, 1996, 88 (01) : 242 - 251
  • [39] FULMINANT EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS FOLLOWING OKT3-THERAPY
    CANFIELD, CW
    HUDNALL, SD
    COLONNA, JO
    BUSUTTIL, RW
    WILKINSON, AH
    DANOVITCH, G
    SHAKED, A
    GOLDSTEIN, L
    ROSENTHAL, JT
    [J]. CLINICAL TRANSPLANTATION, 1992, 6 (01) : 1 - 9
  • [40] A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas
    Ando, Midori
    Sato, Yasuharu
    Takata, Katsuyoshi
    Nomoto, Junko
    Nakamura, Shigeo
    Ohshima, Koichi
    Takeuchi, Tamotsu
    Orita, Yorihisa
    Kobayashi, Yukio
    Yoshino, Tadashi
    [J]. PLOS ONE, 2013, 8 (02):
12345